Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer

NCT00009958 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

42

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: recombinant fowlpox-CEA(6D)/TRICOM vaccine
BIOLOGICAL: recombinant vaccinia-CEA(6D)-TRICOM vaccine
BIOLOGICAL: sargramostim
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)